Inogen (INGN) Cost of Revenue (2016 - 2026)
Inogen has reported Cost of Revenue over the past 13 years, most recently at -$50.2 million for Q4 2025.
- Quarterly Cost of Revenue fell 307.93% to -$50.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $72.1 million through Dec 2025, down 30.0% year-over-year, with the annual reading at $97.7 million for FY2025, 5.22% down from the prior year.
- Cost of Revenue was -$50.2 million for Q4 2025 at Inogen, down from $51.1 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $107.5 million in Q4 2023 and troughed at -$50.2 million in Q4 2025.
- The 5-year median for Cost of Revenue is $37.1 million (2021), against an average of $36.6 million.
- Year-over-year, Cost of Revenue soared 110.83% in 2021 and then crashed 307.93% in 2025.
- A 5-year view of Cost of Revenue shows it stood at $51.9 million in 2021, then rose by 12.98% to $58.6 million in 2022, then skyrocketed by 83.42% to $107.5 million in 2023, then tumbled by 77.54% to $24.2 million in 2024, then crashed by 307.93% to -$50.2 million in 2025.
- Per Business Quant, the three most recent readings for INGN's Cost of Revenue are -$50.2 million (Q4 2025), $51.1 million (Q3 2025), and $25.4 million (Q2 2025).